✦ LIBER ✦

Histoculture drug response assay for gefitinib in non-small-cell lung cancer

✍ Scribed by Tatsuya Yoshimasu; Fuminori Ohta; Shoji Oura; Takeshi Tamaki; Yukio Shimizu; Koma Naito; Megumi Kiyoi; Yoshimitsu Hirai; Mitsumasa Kawago; Yoshitaka Okamura

Book ID: 107497595
Publisher: Springer Japan
Year: 2009
Tongue: Japanese
Weight: 214 KB
Volume: 57
Category: Article
ISSN: 1863-6705
DOI: 10.1007/s11748-008-0332-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib therapy for non-small cell lun

Gefitinib therapy for non-small cell lung cancer

✍ Ariel Birnbaum; Neal Ready 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 190 KB

Erlotinib in advanced non-small-cell lun

Erlotinib in advanced non-small-cell lung cancer after gefitinib failure

✍ Zheng-Tao Zhou; Xin-Hua Xu; Qing Wei; Ming-qian Lu; Jie Wang; Cai-Hong Wen 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 262 KB

Gefitinib is effective for pathological

Gefitinib is effective for pathological fracture of metastatic non-small cell lung cancer

✍ Manabu Hoshi; Masatsugu Takami; Makoto Ieguchi; Kunio Takaoka 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 260 KB

Gefitinib in the treatment of 41 cases w

Gefitinib in the treatment of 41 cases with refractory non-small cell lung cancer

✍ Jianfang Xu; Caicun Zhou; Aiwu Li 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 76 KB

A population-based study of gefitinib in

A population-based study of gefitinib in patients with non-small cell lung cancer

✍ Kenji Hayashibara; Hiroaki Satoh; Yoko Shinohara; Masaharu Inagaki; Takayuki Kab 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 224 KB

The relationship between drug exposure a

The relationship between drug exposure and clinical outcomes of non-small cell lung cancer patients treated with gefitinib

✍ Yuan-Yuan Zhao; Su Li; Yang Zhang; Hong-Yun Zhao; Hai Liao; Ying Guo; Yan-Xia Sh 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 174 KB